163 related articles for article (PubMed ID: 18415107)
1. [Tamoxifen retinopathy: a case series of clinical and functional data].
Ritter C; Renner AB; Wachtlin J; Bechrakis NE; Krause L
Ophthalmologe; 2008 Jun; 105(6):544-9. PubMed ID: 18415107
[TBL] [Abstract][Full Text] [Related]
2. [Unusual symptoms for tamoxifen-associated maculopathy].
Hager T; Hoffmann S; Seitz B
Ophthalmologe; 2010 Aug; 107(8):750-2. PubMed ID: 20393723
[TBL] [Abstract][Full Text] [Related]
3. Multifocal ERG in chloroquine retinopathy: regional variance of retinal dysfunction.
Kellner U; Kraus H; Foerster MH
Graefes Arch Clin Exp Ophthalmol; 2000 Jan; 238(1):94-7. PubMed ID: 10664060
[TBL] [Abstract][Full Text] [Related]
4. The Effects of Adjuvant Tamoxifen Use on Macula Pigment Epithelium Optical Density, Visual Acuity and Retinal Thickness in Patients with Breast Cancer.
Bicer T; Imamoglu GI; Caliskan S; Bicer BK; Gurdal C
Curr Eye Res; 2020 May; 45(5):623-628. PubMed ID: 31684771
[No Abstract] [Full Text] [Related]
5. The multifocal pattern electroretinogram in chloroquine retinopathy.
Neubauer AS; Stiefelmeyer S; Berninger T; Arden GB; Rudolph G
Ophthalmic Res; 2004; 36(2):106-13. PubMed ID: 15017107
[TBL] [Abstract][Full Text] [Related]
6. Tamoxifen side effects, age-related macular degeneration (AMD) or cancer associated retinopathy (CAR)?
Sadowski B; Kriegbaum C; Apfelstedt-Sylla E
Eur J Ophthalmol; 2001; 11(3):309-12. PubMed ID: 11681514
[TBL] [Abstract][Full Text] [Related]
7. TAMOXIFEN RETINOPATHY DURING TREATMENT OF AN INOPERABLE DESMOID TUMOR.
Furst M; Somogyi MB; Wong RW; Araujo D; Harper CA
Retin Cases Brief Rep; 2020; 14(3):268-270. PubMed ID: 29227350
[TBL] [Abstract][Full Text] [Related]
8. Spectral Domain OCT Imaging Techniques in Tamoxifen Retinopathy.
Neuville J; Yevseyenkov V
Optom Vis Sci; 2015 Feb; 92(2):e55-9. PubMed ID: 25525894
[TBL] [Abstract][Full Text] [Related]
9. [Electrophysiological studies in breast carcinoma patients with tamoxifen retinopathy].
Kuchenbecker J; Pump-Schmidt C; Olbricht S; Weise W; Behrens-Baumann W
Ophthalmologe; 2001 Jan; 98(1):81-5. PubMed ID: 11220276
[TBL] [Abstract][Full Text] [Related]
10. Retinal toxicity of high-dose hydroxychloroquine in patients with chronic graft-versus-host disease.
Navajas EV; Krema H; Hammoudi DS; Lipton JH; Simpson ER; Boyd S; Easterbrook M
Can J Ophthalmol; 2015 Dec; 50(6):442-50. PubMed ID: 26651304
[TBL] [Abstract][Full Text] [Related]
11. Abnormal multifocal electroretinogram (mfERG) in ethambutol toxicity.
Kardon RH; Morrisey MC; Lee AG
Semin Ophthalmol; 2006; 21(4):215-22. PubMed ID: 17182409
[TBL] [Abstract][Full Text] [Related]
12. Linezolid induced retinopathy.
Park DH; Park TK; Ohn YH; Park JS; Chang JH
Doc Ophthalmol; 2015 Dec; 131(3):237-44. PubMed ID: 26526593
[TBL] [Abstract][Full Text] [Related]
13. Retinal toxicity associated with hydroxychloroquine and chloroquine: risk factors, screening, and progression despite cessation of therapy.
Michaelides M; Stover NB; Francis PJ; Weleber RG
Arch Ophthalmol; 2011 Jan; 129(1):30-9. PubMed ID: 21220626
[TBL] [Abstract][Full Text] [Related]
14. Ocular toxicity in low-dose tamoxifen: a prospective study.
Noureddin BN; Seoud M; Bashshur Z; Salem Z; Shamseddin A; Khalil A
Eye (Lond); 1999 Dec; 13 ( Pt 6)():729-33. PubMed ID: 10707134
[TBL] [Abstract][Full Text] [Related]
15. Optical coherence tomography findings in tamoxifen retinopathy.
Gualino V; Cohen SY; Delyfer MN; Sahel JA; Gaudric A
Am J Ophthalmol; 2005 Oct; 140(4):757-8. PubMed ID: 16226541
[TBL] [Abstract][Full Text] [Related]
16. Tamoxifen retinopathy: does it really exist?
Lazzaroni F; Scorolli L; Pizzoleo CF; Savini G; De Nigris A; Giosa F; Meduri RA
Graefes Arch Clin Exp Ophthalmol; 1998 Sep; 236(9):669-73. PubMed ID: 9782427
[TBL] [Abstract][Full Text] [Related]
17. Peripheral retinopathy and maculopathy in high-dose tamoxifen therapy.
Bourla DH; Sarraf D; Schwartz SD
Am J Ophthalmol; 2007 Jul; 144(1):126-8. PubMed ID: 17601434
[TBL] [Abstract][Full Text] [Related]
18. Multifocal electroretinography, color discrimination and ocular toxicity in tamoxifen use.
Salomão SR; Watanabe SE; Berezovsky A; Motono M
Curr Eye Res; 2007 Apr; 32(4):345-52. PubMed ID: 17453956
[TBL] [Abstract][Full Text] [Related]
19. Early hydroxychloroquine retinopathy: optical coherence tomography abnormalities preceding Humphrey visual field defects.
Garrity ST; Jung JY; Zambrowski O; Pichi F; Su D; Arya M; Waheed NK; Duker JS; Chetrit Y; Miserocchi E; Giuffrè C; Kaden TR; Querques G; Souied EH; Freund KB; Sarraf D
Br J Ophthalmol; 2019 Nov; 103(11):1600-1604. PubMed ID: 30819690
[TBL] [Abstract][Full Text] [Related]
20. Screening for ocular toxicity in asymptomatic patients treated with tamoxifen.
Heier JS; Dragoo RA; Enzenauer RW; Waterhouse WJ
Am J Ophthalmol; 1994 Jun; 117(6):772-5. PubMed ID: 7880223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
